It is a life sciences public limited company based in Adilabad, Telangana, India, established in 2007.
2007 | Adilabad, Telangana, India | Under LiquidationG S Biotech Limited, a under liquidation public limited company, was established on 12 June 2007 in Adilabad, Telangana, India. Engaging in biotechnology within the trade sector, it holds CIN: U01403TG2007PLC054391. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.70 M.
It upholds a active non-compliant status. Its leadership includes Rajesh Chillale (Irp/Rp/Liquidator), Sanjay Kumar Agarwal (Director), Umeshkumar Agarwal (Director). Past directors included Manoj Kumar Agarwal. It holds ₹351.55 Cr open charges and no settled loans. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at Plot No. 22 & 23 G S Estates, Adilabad, Telangana, 504001.
U01403TG2007PLC054391
054391
12 June 2007
₹1.00 Cr
₹1.70 M
Roc Hyderabad
Unlisted
Under Liquidation
Explore comprehensive insights into G S Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Chillale | Irp/Rp/Liquidator | 15 Jan 2025 | Current |
| Sanjay Kumar Agarwal | Director | 12 Jun 2007 | Current |
| Umeshkumar Agarwal | Director | 12 Jun 2007 | Current |
| Dhananiwala Adit Kumar | Director | 03 Sep 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Sep 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
G S Biotech Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 96.04% decrease. The company also saw a substantial improvement in profitability, with a 16.62% increase in profit. The company's net worth dipped by a decrease of 1.29%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, G S Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,515,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2013 | Canbank Factors Limited | ₹3.00 Cr | Open |
| 12 Oct 2012 | State Bank Of Mauritius Ltd | ₹19.80 Cr | Open |
| 11 Oct 2012 | State Bank Of Mauritius Ltd | ₹18.00 Cr | Open |
| 10 Jul 2012 | State Bank Of Hyderabad | ₹310.75 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with G S Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of G S Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped G S Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rajesh Chillale was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 15 Jan 2025 & has been associated with this company since 11 months 30 days . was recorded as a recent event.
The activity G S Biotech Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was completed.
Progress on G S Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Hyderabad. was documented.
The activity Dhananiwala Adit Kumar was appointed as a Director was appointed as a Director on 03 Sep 2014 & has been associated with this company since 11 years 4 months . was completed.
Progress on A charge with Canbank Factors Limited amounted to Rs. 3.00 Cr with Charge ID 10422069 was registered on 30 Mar 2013. was documented.
Progress on A charge with State Bank Of Mauritius Ltd of Rs. 19.80 Cr registered on 12 Oct 2012 with Charge ID 10387049 was modified on 07 Feb 2013. was documented.
The CIN of G S Biotech Limited is U01403TG2007PLC054391.
G S Biotech Limited is headquartered at Plot No. 22 & 23 G S Estates, Adilabad, Telangana, 504001.
G S Biotech Limited was incorporated on 12 June 2007.
The current directors of G S Biotech Limited are
The primary industry of G S Biotech Limited is Trade.
G S Biotech Limited is unlisted.
The authorized capital of G S Biotech Limited is ₹1.00 Cr, and the paid-up capital is ₹1.70 M.
The compliance status of G S Biotech Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX